Anti-CD20 therapies – Mechanisms of action


Provides information on CD20, binding epitopes of anti-CD20 monoclonal antibodies (rituximab, ocrelizumab, ofatumumab, ublituximab) and the effects of anti-CD20 MAbs in multiple sclerosis. Includes slides explaining antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC).

12 slides

SARS-CoV-2 variants


Summarizes recent data on the UK (B.1.1.7), Brazil (P.1) and South Africa (B.1.351) variants. Also included are the number of variant cases reported in Canada and the U.S. as of March 9, 2021.

9 slides